Maven Income and Growth VCT 3 PLC Issue of Equity

RNS Number : 2438D

Maven Income and Growth VCT 3 PLC

06 September 2024

 

Maven Income and Growth VCT 3 PLC

 

Issue of Equity - Dividend Investment Scheme

 

 

The Board of Maven Income and Growth VCT 3 PLC (the Company) confirms that, on 6 September 2024 and under its Dividend Investment Scheme (DIS), the Company issued and allotted 245,950 new ordinary shares of 10p each (Ordinary Shares) at a price of 52.01p per share which, under the Terms and Conditions of the DIS, is equivalent to the latest announced net asset value per share.

 

As a result, and in accordance with the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules, the Company confirms that its issued share capital as at 6 September 2024 comprises 122,205,331 Ordinary Shares, with each share carrying one voting right. The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required, under the Disclosure, Guidance and Transparency Rules, to notify their interest, or a change to their interest, in the Company.

 

Application will be made to the FCA and the London Stock Exchange for the new Ordinary Shares issued under the DIS to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that admission will become effective and dealings will commence on, or around, 11 September 2024.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

6 September 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

IOEFIFIAAIIRIIS